E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 9/19/2006 in the Prospect News Biotech Daily and Prospect News PIPE Daily.

New Issue: Genta secures $16 million from direct placement of stock

By Sheri Kasprzak

New York, Sept. 19 - Genta Inc. plans to close a $16 million direct placement.

The company will issue 20 million shares at $0.80 each to a group of institutional investors.

The shares are being sold under the company's shelf registration.

The deal is slated to close Sept. 22.

Rodman & Renshaw, LLC was the placement agent.

Located in Berkley Heights, N.J., Genta is a biopharmaceutical company focused on treatments for cancer.

Issuer:Genta Inc.
Issue:Stock
Amount:$16 million
Shares:20 million
Price:$0.80
Warrants:No
Placement agent:Rodman & Renshaw, LLC
Announcement date:Sept. 19
Settlement date:Sept. 22
Stock symbol:Nasdaq: GNTA
Stock price:$1.10 at close Sept. 19

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.